1. From the University of Cambridge, Department of Hematology, MRC Centre, Cambridge, United Kingdom (UK); the Department of Hematology, Addenbrooke's Hospital, Cambridge, UK; the Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK; and the Department of Hematology and Cytogenetics, Christie's Hospital, Manchester, UK.